Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT-planned radiotherapy of high-grade meningiomas

被引:19
|
作者
Zollner, Barbara [1 ]
Ganswindt, Ute [1 ]
Maihoefer, Cornelius [1 ]
Corradini, Stefanie [1 ]
Albert, Nathalie Lisa [2 ]
Schichor, Christian [3 ]
Belka, Claus [1 ,4 ,5 ]
Niyazi, Maximilian [1 ,4 ,5 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany
[4] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany
[5] German Canc Res Ctr, Heidelberg, Germany
来源
RADIATION ONCOLOGY | 2018年 / 13卷
关键词
Atypical and anaplastic meningioma; Radiotherapy; Recurrence pattern; Safety margin; IMRT; STEREOTACTIC RADIOTHERAPY; ANAPLASTIC MENINGIOMAS; ADJUVANT RADIOTHERAPY; PROTON THERAPY; DIAGNOSIS; SURVIVAL; FAILURE; CLASSIFICATION; IRRADIATION; TUMORS;
D O I
10.1186/s13014-018-1056-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of the present study was to evaluate the influence of the applied safety margins of modern intensity-modulated radiotherapy (IMRT) in patients with high-grade meningiomas on local control and recurrence patterns. Methods: Twenty patients with a neuropathological diagnosis of a high-grade meningioma (WHO degrees II or degrees III) treated with adjuvant or definitive radiotherapy between 2010 and 2015 were included in the present retrospective analysis. All patients were planned PET-based. Recurrence patterns were assessed by means of MRI and/or DOTATATE-PET/computertomography (CT). Results: The median follow-up was 31.0 months [95% confidence interval (CI): 20.1-42.0] and the progressionfree survival (PFS) after 24 months was 87.5%. Overall, four patients had a local recurrence of their meningioma. Of these, three were located in field according to the prior radiotherapy treatment region, while only one patient had a distant relapse. There were no independent factors influencing progression-free or overall survival (OS). Conclusion: After radiotherapy (RT), patients with atypical or anaplastic meningiomas still have a defined risk of tumor recurrence. The aim of the present study was to examine mono-institutional data concerning target volume definition and recurrence patterns after radiotherapy of high-grade meningiomas as there are limited data available. Our data suggest that extended safety margins are necessary to achieve a favorable local control for high-grade meningiomas.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] 18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy
    Mapelli, Paola
    Zerbetto, Flavia
    Incerti, Elena
    Conte, Gian Marco
    Bettinardi, Valentino
    Fallanca, Federico
    Anzalone, Nicoletta
    Di Muzio, Nadia
    Gianolli, Luigi
    Picchio, Maria
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (12) : E525 - E526
  • [42] In vivo investigation of c-x-c chemokine receptor type 4 in Treatment-naive High-grade Anaplastic Glioma using [68Ga] Ga-cxcr4 pet/ct
    Roustaei, H.
    Anvari, K.
    Vosoughi, H.
    Shafiei, S.
    Norouzbeigi, N.
    Aryana, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S356 - S356
  • [43] 68Ga-PSMA PET/CT in Initial Diagnosis and Bone Metastasis Evaluation in Saudi Patients with High-Grade Prostate Cancer
    Mansour, Sahar
    Al-Khalaf, Meshael
    Al-Hantoshi, Sarah
    Al-Mutairi, Mead
    Al-Asqah, Fatima
    Al-Subaie, Nouf
    Al-Qarni, Sadeem
    Suwaylim, Futun
    Alkhodiri, Rawan F.
    Faden, Ola
    Albatly, Abdulrahman
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2024, 14 (01) : 72 - 76
  • [44] ROLE OF 68GA-PSMA-PET/CT IN THE MANAGEMENT OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: A RETROSPECTIVE ANALYSIS
    Frassinelli, Luca
    Mazzeo, Ercole
    Lanfranchi, Bianca
    Rubino, Laura
    Aluisio, Giovanni
    Prandini, Napoleone
    Vernaleone, Marco
    Scarlattei, Maura
    Ruffini, Livia
    Lohr, Frank
    Bruni, Alessio
    ANTICANCER RESEARCH, 2019, 39 (03) : 1534 - 1535
  • [45] High degree of implementation of intended management changes after 68Ga-DOTATATE PET/CT imaging in patients with neuroendocrine tumors.
    Calais, Jeremie
    Fendler, Wolfgang
    Eiber, Matthias
    Wolin, Edward
    Slavik, Roger
    Barrio, Martin
    Gupta, Pawan
    Quon, Andrew
    Schiepers, Christiaan
    Auerbach, Martin
    Czernin, Johannes
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [46] [68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma
    Truckenmueller, Peter
    Graef, Josefine
    Scheel, Michael
    Vajkoczy, Peter
    Capper, David
    Kaul, David
    Furth, Christian
    Amthauer, Holger
    Brenner, Winfried
    Onken, Julia Sophie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans
    Gupta, Khushboo
    Jadhav, Rahul
    Singh, Jagadeseh
    Prasad, Rameshwar
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [48] Evaluating [68Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study
    Di Giorgio, Andrea
    Rapa, Marco
    Civollani, Simona
    Farolfi, Andrea
    Fanti, Stefano
    CURRENT ONCOLOGY, 2025, 32 (01)
  • [49] 68Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer
    Pfister, David
    Haidl, Friederike
    Nestler, Tim
    Verburg, Frederik
    Schmidt, Matthias
    Wittersheim, Maike
    Steib, Florain
    Heidenreich, Axel
    BJU INTERNATIONAL, 2020, 126 (06) : 679 - 683
  • [50] 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy
    Artigas, C.
    Flamen, P.
    Charlier, F.
    Levillain, H.
    Wimana, Z.
    Diamand, R.
    Albisinni, S.
    Gil, T.
    Van Velthoven, R.
    Peltier, A.
    Van Gestel, D.
    Roumeguere, T.
    Otte, F. -X.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (08) : 1535 - 1542